ACM Global expands global footprint with Asia Pacific acquisition
ACM Global Central Laboratory (ACM Global), a diagnostic central laboratory specializing in delivering high-quality testing services, has acquired Phoenix Pharma Central Services (Phoenix PCS), a central laboratory services provider for Asia Pacific clinical trials with lab facilities in Singapore and Shanghai, China. Terms of the transaction were not disclosed.
Working with partner labs in India, Australia and China, ACM Global has provided central lab services in Asia Pacific for more than 15 years. By acquiring Phoenix PCS, ACM Global gains an established, fully-operational lab in the heart of Singapore offering a local team with clinical trials experience and knowledge of regional regulatory requirements, country specific logistics and familiarity with customs and local languages. Additionally, ACM Global will acquire Phoenix PCS’ brand new lab in Shanghai.
“This acquisition is a major milestone in our organization’s growth and represents a significant investment and commitment to the region,” said Angela J. Panzarella, president of ACM Medical Laboratory, parent company of ACM Global Central Laboratory. “We have a long and successful history of working with partner labs in Asia, but it was important for us to establish a network of ACM Global-owned and operated labs in the Asia-Pacific region, which we see as an increasingly important region for clinical research.”
Established in 2001, Phoenix PCS offers services for phase I to phase IV clinical trials and has been accredited by the College of American Pathologists (CAP) since 2003. Founder and CEO of Phoenix PCS Chiew Yan Lee, Ph.D., FRCPath, has more than 20 years of experience in central lab operations within Asia Pacific. Lee will continue as director, Singapore and Shanghai operations.
The ACM Singapore facility is located just five minutes from the Singapore International Airport and the city’s logistics hub. The new Shanghai lab is purpose designed to optimize the company’s lab processes. Both labs will be equipped with ACM’s standard technology platforms and instrumentation to enable seamless integration with ACM Global’s operations in the U.S., U.K. and India, resulting in a single global database with harmonized test data for all global projects.
ACM in 2013 moved its European lab operations into a new, purpose built and expanded facility in York, England. Since 1994, ACM Global has provided central laboratory testing services to more than 2,300 clinical studies, involving more than 7,000 sites in 60 countries.